If you need more lookups,
subscriptions start at $34 USD/month.
Vijay Kaiwar Location
India
Vijay Kaiwar Work
Chief Executive Officer @ (August 2025 - Present)
Vice President Operations @ (April 2024 - June 2025)
Vice President-CRAMS and Strategic API tegic Marketing and Business Development @ (September 2016 - March 2024)
Vice President - Head Business Development, CRAMS @ (October 2013 - August 2016)
Associate Vice President - CRAMS Division @ (September 2011 - October 2013)
Head Business Development ES and Fine Chemicals ( GM ) @ (April 2009 - August 2011)
Growth Unit Head - CRAMS Business @ (April 2006 - March 2009)
Sr . Business Development Manager – Intermediates and Pharmaceutical Division @ (April 2002 - March 2006)
Scientist - - Agro and Pharmaceuticals Division @ (June 1995 - March 2002)
Vijay Kaiwar Education
King's College London, U. of London
Post-Doc (Nucleoside Chemistry)
1993-1995
CSIR-IICT (Indian Institute of Chemical Technology), Hyderabad, India.
Doctor of Philosophy (Ph.D.) (Synthesis of biologically active compounds)
1988-1993
The Scindia School, Gwalior, India. 1974-1983
Vijay Kaiwar Skills
Biotechnology
Lifesciences
R&D
Technology Transfer
Regulatory Affairs
Pharmaceutics
Pharmaceutical Industry
Management
Sop
Business Development
GMP
Drug Discovery
Life Sciences
Medicinal Chemistry
Validation
Drug Development
Organic Chemistry
Chemistry
Leadership
GLP
Customer Service
Strategy
Business Strategy
Microsoft Office
Sales
Vijay Kaiwar Summary
Vijay Kaiwar, based in India, is currently a Chief Executive Officer at Navin Molecular. Vijay Kaiwar brings experience from previous roles at Anthem Biosciences Limited, SUN PHARMA and Aurobindo Pharma. Vijay Kaiwar holds a 1993 - 1995 Post-Doc in Nucleoside Chemistry @ King's College London, U. of London. With a robust skill set that includes Biotechnology, Lifesciences, R&D, Technology Transfer, Regulatory Affairs and more. Vijay Kaiwar has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Vijay Kaiwar?
Find contact details for 700 million professionals.